547 related articles for article (PubMed ID: 25226550)
1. Tauopathy PET and amyloid PET in the diagnosis of chronic traumatic encephalopathies: studies of a retired NFL player and of a man with FTD and a severe head injury.
Mitsis EM; Riggio S; Kostakoglu L; Dickstein DL; Machac J; Delman B; Goldstein M; Jennings D; D'Antonio E; Martin J; Naidich TP; Aloysi A; Fernandez C; Seibyl J; DeKosky ST; Elder GA; Marek K; Gordon W; Hof PR; Sano M; Gandy S
Transl Psychiatry; 2014 Sep; 4(9):e441. PubMed ID: 25226550
[TBL] [Abstract][Full Text] [Related]
2. Tau Positron-Emission Tomography in Former National Football League Players.
Stern RA; Adler CH; Chen K; Navitsky M; Luo J; Dodick DW; Alosco ML; Tripodis Y; Goradia DD; Martin B; Mastroeni D; Fritts NG; Jarnagin J; Devous MD; Mintun MA; Pontecorvo MJ; Shenton ME; Reiman EM
N Engl J Med; 2019 May; 380(18):1716-1725. PubMed ID: 30969506
[TBL] [Abstract][Full Text] [Related]
3. Cerebral [
Dickstein DL; Pullman MY; Fernandez C; Short JA; Kostakoglu L; Knesaurek K; Soleimani L; Jordan BD; Gordon WA; Dams-O'Connor K; Delman BN; Wong E; Tang CY; DeKosky ST; Stone JR; Cantu RC; Sano M; Hof PR; Gandy S
Transl Psychiatry; 2016 Sep; 6(9):e900. PubMed ID: 27676441
[TBL] [Abstract][Full Text] [Related]
4. Amyloid PET across the cognitive spectrum in former professional and college American football players: findings from the DIAGNOSE CTE Research Project.
Stern RA; Trujillo-Rodriguez D; Tripodis Y; Pulukuri SV; Alosco ML; Adler CH; Balcer LJ; Bernick C; Baucom Z; Marek KL; McClean MD; Johnson KA; McKee AC; Stein TD; Mez J; Palmisano JN; Cummings JL; Shenton ME; Reiman EM;
Alzheimers Res Ther; 2023 Oct; 15(1):166. PubMed ID: 37798671
[TBL] [Abstract][Full Text] [Related]
5. In vivo characterization of chronic traumatic encephalopathy using [F-18]FDDNP PET brain imaging.
Barrio JR; Small GW; Wong KP; Huang SC; Liu J; Merrill DA; Giza CC; Fitzsimmons RP; Omalu B; Bailes J; Kepe V
Proc Natl Acad Sci U S A; 2015 Apr; 112(16):E2039-47. PubMed ID: 25848027
[TBL] [Abstract][Full Text] [Related]
6. [18F]-T807 tauopathy PET imaging in chronic traumatic encephalopathy.
Gandy S; DeKosky ST
F1000Res; 2014; 3():229. PubMed ID: 25469232
[TBL] [Abstract][Full Text] [Related]
7. Case Report:
Krishnadas N; Doré V; Lamb F; Groot C; McCrory P; Guzman R; Mulligan R; Huang K; O'Donnell M; Ponsford J; Hopwood M; Villemagne VL; Rowe CC
Front Neurol; 2020; 11():598980. PubMed ID: 33414760
[No Abstract] [Full Text] [Related]
8. 18F-florbetapir PET in patients with frontotemporal dementia and Alzheimer disease.
Kobylecki C; Langheinrich T; Hinz R; Vardy ER; Brown G; Martino ME; Haense C; Richardson AM; Gerhard A; Anton-Rodriguez JM; Snowden JS; Neary D; Pontecorvo MJ; Herholz K
J Nucl Med; 2015 Mar; 56(3):386-91. PubMed ID: 25655625
[TBL] [Abstract][Full Text] [Related]
9. Tau PET and multimodal brain imaging in patients at risk for chronic traumatic encephalopathy.
Lesman-Segev OH; La Joie R; Stephens ML; Sonni I; Tsai R; Bourakova V; Visani AV; Edwards L; O'Neil JP; Baker SL; Gardner RC; Janabi M; Chaudhary K; Perry DC; Kramer JH; Miller BL; Jagust WJ; Rabinovici GD
Neuroimage Clin; 2019; 24():102025. PubMed ID: 31670152
[TBL] [Abstract][Full Text] [Related]
10. Correlation of amyloid PET ligand florbetapir F 18 binding with Aβ aggregation and neuritic plaque deposition in postmortem brain tissue.
Choi SR; Schneider JA; Bennett DA; Beach TG; Bedell BJ; Zehntner SP; Krautkramer MJ; Kung HF; Skovronsky DM; Hefti F; Clark CM
Alzheimer Dis Assoc Disord; 2012; 26(1):8-16. PubMed ID: 22354138
[TBL] [Abstract][Full Text] [Related]
11. Traumatic brain injury (TBI) in collision sports: Possible mechanisms of transformation into chronic traumatic encephalopathy (CTE).
VanItallie TB
Metabolism; 2019 Nov; 100S():153943. PubMed ID: 31610856
[TBL] [Abstract][Full Text] [Related]
12. Postmortem Autopsy-Confirmation of Antemortem [F-18]FDDNP-PET Scans in a Football Player With Chronic Traumatic Encephalopathy.
Omalu B; Small GW; Bailes J; Ercoli LM; Merrill DA; Wong KP; Huang SC; Satyamurthy N; Hammers JL; Lee J; Fitzsimmons RP; Barrio JR
Neurosurgery; 2018 Feb; 82(2):237-246. PubMed ID: 29136240
[TBL] [Abstract][Full Text] [Related]
13. Evidence of increased brain amyloid in severe TBI survivors at 1, 12, and 24 months after injury: report of 2 cases.
Gatson JW; Stebbins C; Mathews D; Harris TS; Madden C; Batjer H; Diaz-Arrastia R; Minei JP
J Neurosurg; 2016 Jun; 124(6):1646-53. PubMed ID: 26613169
[TBL] [Abstract][Full Text] [Related]
14. Focal amyloid and asymmetric tau in an imaging-to-autopsy case of clinical primary progressive aphasia with Alzheimer disease neuropathology.
Martersteck A; Ayala I; Ohm DT; Spencer C; Coventry C; Weintraub S; Bigio EH; Mesulam M-; Geula C; Rogalski E
Acta Neuropathol Commun; 2022 Aug; 10(1):111. PubMed ID: 35945628
[TBL] [Abstract][Full Text] [Related]
15. Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition.
Pontecorvo MJ; Devous MD; Navitsky M; Lu M; Salloway S; Schaerf FW; Jennings D; Arora AK; McGeehan A; Lim NC; Xiong H; Joshi AD; Siderowf A; Mintun MA;
Brain; 2017 Mar; 140(3):748-763. PubMed ID: 28077397
[TBL] [Abstract][Full Text] [Related]
16. Impact of ¹⁸F-florbetapir PET imaging of β-amyloid neuritic plaque density on clinical decision-making.
Zannas AS; Doraiswamy PM; Shpanskaya KS; Murphy KR; Petrella JR; Burke JR; Wong TZ
Neurocase; 2014 Aug; 20(4):466-73. PubMed ID: 23672654
[TBL] [Abstract][Full Text] [Related]
17. A consecutive case series experience with [18 F] florbetapir PET imaging in an urban dementia center: impact on quality of life, decision making, and disposition.
Mitsis EM; Bender HA; Kostakoglu L; Machac J; Martin J; Woehr JL; Sewell MC; Aloysi A; Goldstein MA; Li C; Sano M; Gandy S
Mol Neurodegener; 2014 Feb; 9():10. PubMed ID: 24484858
[TBL] [Abstract][Full Text] [Related]
18. Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-β plaques: a prospective cohort study.
Clark CM; Pontecorvo MJ; Beach TG; Bedell BJ; Coleman RE; Doraiswamy PM; Fleisher AS; Reiman EM; Sabbagh MN; Sadowsky CH; Schneider JA; Arora A; Carpenter AP; Flitter ML; Joshi AD; Krautkramer MJ; Lu M; Mintun MA; Skovronsky DM;
Lancet Neurol; 2012 Aug; 11(8):669-78. PubMed ID: 22749065
[TBL] [Abstract][Full Text] [Related]
19. Clinical utility of amyloid PET imaging with (18)F-florbetapir: a retrospective study of 100 patients.
Carswell CJ; Win Z; Muckle K; Kennedy A; Waldman A; Dawe G; Barwick TD; Khan S; Malhotra PA; Perry RJ
J Neurol Neurosurg Psychiatry; 2018 Mar; 89(3):294-299. PubMed ID: 29018162
[TBL] [Abstract][Full Text] [Related]
20. Region-Specific Association of Subjective Cognitive Decline With Tauopathy Independent of Global β-Amyloid Burden.
Buckley RF; Hanseeuw B; Schultz AP; Vannini P; Aghjayan SL; Properzi MJ; Jackson JD; Mormino EC; Rentz DM; Sperling RA; Johnson KA; Amariglio RE
JAMA Neurol; 2017 Dec; 74(12):1455-1463. PubMed ID: 28973551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
